D.E. Shaw & Co

D.E. Shaw & Co Portfolio holdings

AUM $100B
1-Year Return 23.04%
 

D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.

This Quarter Return
+3.39%
1 Year Return
+23.04%
3 Year Return
+72.12%
5 Year Return
+130.88%
10 Year Return
+299.18%
AUM
$49.6B
AUM Growth
+$2.17B
Cap. Flow
+$74.5M
Cap. Flow %
0.15%
Top 10 Hldgs %
11.95%
Holding
2,764
New
288
Increased
929
Reduced
1,086
Closed
306

Sector Composition

1 Technology 16.75%
2 Healthcare 14.22%
3 Consumer Discretionary 11.66%
4 Financials 11.15%
5 Communication Services 9.6%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ANDAR
2301
DELISTED
Andina Acquisition Corp. II Right
ANDAR
$68K ﹤0.01%
154,200
-2,500
-2% -$1.1K
STLRW
2302
DELISTED
Stellar Acquisition III Inc. Warrants
STLRW
$66K ﹤0.01%
205,000
HOV icon
2303
Hovnanian Enterprises
HOV
$906M
$65K ﹤0.01%
924
-437
-32% -$30.7K
MACQW
2304
DELISTED
M I Acquisitions, Inc. Warrant
MACQW
$64K ﹤0.01%
205,000
CASC
2305
DELISTED
Cascadian Therapeutics, Inc.
CASC
$63K ﹤0.01%
16,962
-49,697
-75% -$185K
EXK
2306
Endeavour Silver
EXK
$1.71B
$62K ﹤0.01%
20,323
+7,557
+59% +$23.1K
COOP icon
2307
Mr. Cooper
COOP
$13.8B
$60K ﹤0.01%
4,005
+2,064
+106% +$30.9K
SRRA
2308
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$60K ﹤0.01%
1,273
-857
-40% -$40.4K
FCEL icon
2309
FuelCell Energy
FCEL
$118M
$59K ﹤0.01%
132
+103
+355% +$46K
ANDAW
2310
DELISTED
Andina Acquisition Corp. II Warrant
ANDAW
$58K ﹤0.01%
194,900
NDLS icon
2311
Noodles & Co
NDLS
$30.9M
$57K ﹤0.01%
14,635
-2,543
-15% -$9.9K
GLBL
2312
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$57K ﹤0.01%
11,275
MNKD icon
2313
MannKind Corp
MNKD
$1.71B
$55K ﹤0.01%
38,983
-898,005
-96% -$1.27M
CGEN icon
2314
Compugen
CGEN
$136M
$54K ﹤0.01%
+14,083
New +$54K
EPE
2315
DELISTED
EP Energy Corporation
EPE
$52K ﹤0.01%
+14,237
New +$52K
PTX
2316
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$51K ﹤0.01%
+12,609
New +$51K
CFMS
2317
DELISTED
Conformis, Inc. Common Stock
CFMS
$50K ﹤0.01%
+467
New +$50K
KNDI
2318
Kandi Technologies Group
KNDI
$114M
$47K ﹤0.01%
10,504
TDW icon
2319
Tidewater
TDW
$2.89B
$47K ﹤0.01%
1,993
+600
+43% +$14.2K
FRSH
2320
DELISTED
Papa Murphy's Holdings, Inc
FRSH
$47K ﹤0.01%
10,770
-56,963
-84% -$249K
CLDX icon
2321
Celldex Therapeutics
CLDX
$1.55B
$46K ﹤0.01%
1,237
-2,696
-69% -$100K
MMDMR
2322
DELISTED
Modern Media Acquisition Corp. Right
MMDMR
$46K ﹤0.01%
+115,300
New +$46K
QHC
2323
DELISTED
Quorum Health Corporation
QHC
$44K ﹤0.01%
10,669
-20,256
-66% -$83.5K
NADL
2324
DELISTED
North Atlantic Drilling Ltd
NADL
$41K ﹤0.01%
+30,529
New +$41K
SID icon
2325
Companhia Siderúrgica Nacional
SID
$1.99B
$40K ﹤0.01%
18,456
+72
+0.4% +$156